The US DoJ is considering joining Texas’ antitrust case against BlackRock (BLK) and State Street (STT)
Newsquawk Staff ·
The US DoJ is considering joining Texas’ antitrust case against BlackRock (BLK) and State Street (STT)
What it means
Federal enforcers joining a state-led antitrust action is a meaningful escalation step: in past episodes of this kind, DoJ participation has tended to signal that a complaint has survived internal legal review and adds discovery resources and litigation credibility that state attorneys general rarely carry alone. The underlying theory here, that large common owners of competing firms can soften competition, has circulated in academic and enforcement circles for years without yet producing a decisive court outcome, so the case sits at the untested end of antitrust doctrine. That matters for the sequence: comparable actions against index providers and asset managers have historically played out over years through motions to dismiss, discovery, and possible settlement, with headline risk concentrated at procedural milestones rather than continuous repricing. The channel to equity value runs through potential remedies, constraints on stewardship or index concentration, rather than through near-term earnings, since passive fee economics are unaffected by litigation alone. Worth watching is whether DoJ formally files, which other states attach, and whether the remedy language targets voting and engagement practices rather than structure, as that distinction separates an operational nuisance from a business-model challenge. The peer read-across is to the other large index franchises named or implied by the same ownership logic.
- US Market Wrap: Tech leads losses; Hawkish Fed bets trimmed on soft headline PPI
- Daily US Equity Opening News: MSFT outage recovery continues; ANT IPO 6x oversubscribed; NSCL needs more financing for ANT deal
- US Broker Moves: PANW upgraded at KeyBanc; AVGO downgraded at Rothschild Redburn
- Daily US Equity Opening News - MSFT outages weigh; ANT IPO six times oversubscribed; NSCL needs more financing for ANT contract; CSCO slips as product & AI orders slow; AMAT Q4 beat; CBRS up after results, MSFT deal; MOD surges on SSNLF talks
- Newsquawk Daily European Equity Opening News - 13th November 2026
Related headlines
- TREASURY WRAP: T-NOTE FUTURES (Z6) SETTLE 8 + TICKS LOWER AT 105-061 day ago
- Newsquawk Daily US Opening News - 13th November 20261 day ago
- [MARKET ANALYSIS] Fixed bearish and at fresh WTD lows into US PPI1 day ago
- EUROPEAN OPEN: CFR SW H1 op profit up sharply; BC8 GY raises EBT outlook; AMS SW Q3 revenue miss; BOSS GY appoints new CEO; STLAM IM faces potential Canada lawsuit; CARLB DC plans USD 600mln India IPO1 day ago
- Weekly US Earnings Estimates: 16-20th November 2026: AI-leader NVDA the highlight, with retailers also in focus1 day ago
- Meta (META) is trialling a new prediction-market app with its employees, WSJ reports1 day ago
- OpenAI reportedly disbands its robotics team, according to Fortune1 day ago
- Nvidia (NVDA) lender consortium in flux after Huang's departure, reports NYT citing sources; no loans have closed, and at least one of the six lenders that had agreed to it was on Thursday discussing dropping out1 day ago
- Nvidia’s (NVDA) board approached Arm (ARM) CEO Rene Haas as a potential successor to Jensen Huang, reports FT citing sources1 day ago
- Microsoft (MSFT) on the outage says it addressed the underlying issue and continue to restore service to remaining customers and regions1 day ago
- OpenAI starts ChatGPT wallet, available to Pro subscribers, CNBC reports1 day ago
- Newsquawk European Market Wrap - 13th November 20261 day ago
- US EQUITY OPEN: Indices pare gains as Tech once again underperforms1 day ago
- US PRE-MARKET MOVERS: NVDA, MSFT, CSCO, CBRS, FLO, MOD, PANW1 day ago
- Merck (MRK) says WELIREG in combination with lenvatinib demonstrated a statistically significant and clinically meaningful improvement in progression-free survival, one of the study's dual primary endpoints, for treatment of ccRCC1 day ago